用潜在空间建模蛋白-片段相互作用,高效发现药物候选物。
Flow-Based Fragment Identification via Binding Site-Specific Latent Representations
- 通过对比学习构建蛋白与片段的共享潜在表示。
- 生成式方法在低计算成本下实现顶尖片段回收率。
- 适合药物研发人员快速筛选有效片段分子。
基于片段的药物设计依赖小分子片段与靶点结合,但初始片段识别困难,因片段常弱结合且非特异。我们开发了基于对比学习的蛋白-片段编码器,将分子片段与蛋白表面映射至共享潜在空间,捕捉关键相互作用特征。在此基础上提出新方法LatentFrag,可条件生成化学上合理的片段嵌入及其位置。该方法在高敏感度下定位蛋白-片段结合位点,并在采样时实现当前最优的片段恢复率。相比传统虚拟筛选,其计算成本仅为几分之一,为片段命中发现提供高效起点。进一步扩展至完整配体设计任务,显著提升片段识别能力,为片段导向药物发现提供实用工具。
原文摘要 · Abstract (English)
Fragment-based drug design is a promising strategy leveraging the binding of small chemical moieties that can efficiently guide drug discovery. The initial step of fragment identification remains challenging, as fragments often bind weakly and non-specifically. We developed a protein-fragment encoder that relies on a contrastive learning approach to map both molecular fragments and protein surfaces in a shared latent space. The encoder captures interaction-relevant features and allows to perform virtual screening as well as generative design with our new method LatentFrag. In LatentFrag, fragment embeddings and positions are generated conditioned on the protein surface while being chemically realistic by construction. Our expressive fragment and protein representations allow location of protein-fragment interaction sites with high sensitivity and we observe state-of-the-art fragment recovery rates when sampling from the learned distribution of latent fragment embeddings. Our generative method outperforms common methods such as virtual screening at a fraction of its computational cost providing a valuable starting point for fragment hit discovery. We further show the practical utility of LatentFrag and extend the workflow to full ligand design tasks. Together, these approaches contribute to advancing fragment identification and provide valuable tools for fragment-based drug discovery.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。